BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28604942)

  • 1. MicroRNAs regulate APOBEC gene expression.
    Cao W; Wu W
    Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
    Cao W; Wu W
    Methods Mol Biol; 2018; 1699():75-81. PubMed ID: 29086369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
    Gao J; Choudhry H; Cao W
    Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Editing by APOBECs: A Genomic Preserver and Transformer.
    Knisbacher BA; Gerber D; Levanon EY
    Trends Genet; 2016 Jan; 32(1):16-28. PubMed ID: 26608778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
    Butler K; Banday AR
    J Hematol Oncol; 2023 Mar; 16(1):31. PubMed ID: 36978147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
    Ito F; Fu Y; Kao SA; Yang H; Chen XS
    J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
    He X; Li J; Wu J; Zhang M; Gao P
    Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3 genes: retroviral restriction factors to cancer drivers.
    Henderson S; Fenton T
    Trends Mol Med; 2015 May; 21(5):274-84. PubMed ID: 25820175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis.
    Chen L; Qiu X; Zhang N; Wang Y; Wang M; Li D; Wang L; Du Y
    Biosci Trends; 2017 Sep; 11(4):383-388. PubMed ID: 28717061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC: A molecular driver in cervical cancer pathogenesis.
    Revathidevi S; Murugan AK; Nakaoka H; Inoue I; Munirajan AK
    Cancer Lett; 2021 Jan; 496():104-116. PubMed ID: 33038491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.
    Koito A; Ikeda T
    Front Microbiol; 2013; 4():28. PubMed ID: 23431045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
    Granadillo Rodríguez M; Flath B; Chelico L
    Open Biol; 2020 Dec; 10(12):200188. PubMed ID: 33292100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBECs orchestrate genomic and epigenomic editing across health and disease.
    Cervantes-Gracia K; Gramalla-Schmitz A; Weischedel J; Chahwan R
    Trends Genet; 2021 Nov; 37(11):1028-1043. PubMed ID: 34353635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.
    Orecchini E; Frassinelli L; Galardi S; Ciafrè SA; Michienzi A
    Chromosome Res; 2018 Mar; 26(1-2):45-59. PubMed ID: 29396793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
    Cho RJ; Alexandrov LB; den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP
    Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular origins of APOBEC-associated mutations in cancer.
    Petljak M; Maciejowski J
    DNA Repair (Amst); 2020 Oct; 94():102905. PubMed ID: 32818816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the APOBEC3 Family Is Associated with a Poor Prognosis and Influences Treatment Response to Raf Inhibitors in Low Grade Glioma.
    Luo C; Wang S; Liao W; Zhang S; Xu N; Xie W; Zhang Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
    Petljak M; Green AM; Maciejowski J; Weitzman MD
    Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of APOBECs in Viral Replication.
    Xu WK; Byun H; Dudley JP
    Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33266042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness.
    Kim K; Calabrese P; Wang S; Qin C; Rao Y; Feng P; Chen XS
    Sci Rep; 2022 Sep; 12(1):14972. PubMed ID: 36100631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.